The Share Centre: The funds, stocks and sectors best equipped to deal with coronavirus turmoil

Outperformers to look out for

clock • 5 min read

Covid-19 has had an impact on each sector in different ways. However, the virus has also shone a light on sectors that have been able to provide some support to portfolios, such as tech and healthcare, both of which have performed well over the course of the year.

We have also seen this feed through into the fund inflows, particularly in European tech, which has seen €5.7bn in inflows, a figure that has already exceeded levels seen in 2019. Investors' demand for tech is strong and goes to show where the appetite is at the minute, with many feeling this will be sustained moving into the future as the role of technology increasingly becomes a more integral part of our lives and the way businesses operate.  Another sector that has continued to progress despite Covid-19 disruption is healthcare. Globally, this sector is benefitting from some strong...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot